BRAINBox

BRAINBox Solutions is developing the first AI-enabled multimodal approach for the diagnosis and prognosis of mild traumatic brain injury (commonly referred to as concussion). The company aims to establish clinical best practice standards for the diagnosis and prognosis of concussions. The product includes a set of proprietary, patented blood biomarkers that can be read in a short time either on point-of-care instruments or using standard laboratory systems, along with neurocognitive testing, to provide a single-system score that measures injury severity and guides treatment. The company is led by key physicians and scientific thought leaders in the field, as well as an experienced, clinically focused management team.